pointed out the enhancing effect of iron on the pathogenicity of Yersinia pestis. Burrows (1962) mentioned that both pigmented virulent strains (P+) and non-pigmented avirulent strains (P-) required iron for growth, and that only virulent strains possessed the ability to utilize tissue-bound iron. Therefore, avirulent strains killed mice only when their in vivo growth was supported by administration of enough amount of iron to the infected animals . This finding gave a warning against the concomitant administration of an antianemic iron drug to the individuals vaccinated with live attenuated vaccine . In this regard, we attempted to examine the above possibility using a clinically available iron drug (Blutal) in mice infected with an attenuated strain EV. 
DISCUSSION
The observation by Jackson and Burrows (1956) that iron salts enhanced the The effect of Blutal on the toxicity of murine toxin * Group I received intraperitoneal injections of 0 .2 ml Blutal 2 hr prior to and 1 day after subcutaneous injection of murine toxin. ** Group II received a subcutaneous injection of 0 .4 ml of the toxin-Blutal mixture after its incubation at 37C for 2 hr. The ratio of Blutal to saline dilution of toxin was 1: 1. *** Group III received a subcutaneous injection of murine toxin dissolved in 0 .2 ml saline. **** Lyophilized murine toxin was weighed and dissolved in sterile saline and then serially diluted at 2-fold steps. Each mouse except Group II received 0.2 ml of dilution subcutaneously. ***** Denominators are numbers of mice challenged and numerators those died within 2 days. Particularly, Martin, Jandl and Finland (1963) suggested that serum transferrin might be the host factor involved in this phenomenon.
In our experiments to see which explanation is more plausible in experimental plague infection, a particular consideration was given to routes for Blutal administration and challenge infection. We thought that the experimental result would largely depend upon the route combination, which may largely affect the direct contact of the bacilli with iron administered simultaneously. We adopted, therefore, the subcutaneous route for EV inoculation and the intraperitoneal route for Blutal administration, so that iron might not reach the bacilli before it had been introduced into the blood circulation in which transf errin and other proteins were present. These serum proteins are known to combine with iron (Bullen et al., 1967 (Bullen et al., , 1968 Martin, Jandl and Finland, 1963) , so only excess free iron will reach the area of EV location to exert its direct effect on the bacilli.
Our experiments differed from those of other authors (Jackson and Burrows, 1956; Bullen et al., 1967 Bullen et al., , 1968 Martin, Jandl and Finland, 1963) also in respect to the challenge route.
They employed the intraperitoneal, intramuscular or intracardial route of infection, but we employed the subcutaneous route. The former routes are considered to cause infection of a septicemic and fatal form even with nonpathogenic strains.
We have found that an intravenous LD50 of a virulent plague strain Yreka for guinea pigs was nearly one-thousandth of a subcutaneous LD50 for the same animals (unpublished data).
The histopathological observations in the present study supported the view that Blutal administration interfered with the defense mechanism of the host. Our previous report (Morita, Yamamoto and Wake, 1970) demonstrated histopathologically the relative lack of invasiveness of the attenuated strain EV.
The observations in the present study, therefore, provided evidences to prove that Blutal administration aided the microbes to invade deeper into the parenchyma) region of the liver tissue. In fact, when Blutal was administered, the microscopic lesions caused by EV strain in the liver and spleen were almost the same in nature as those caused by virulent strains.
The different results between mice and guinea pigs may have been due to the relatively smaller dose of Blutal per kg body weight of the latter animals or to their resistance to the murine toxin. If the latter is the case, the role of the toxin in plague infection appears important.
The toxicity itself was not enhanced by the action of iron, either in vivo or in vitro. The in vitro treatment of murine toxin with Blutal rather decreased the toxicity in our experiment.
A preliminary experiment suggested a detoxifying action of Blutal to make the toxin an immunogenic toxoid (unpublished data), though there are still many problems to be studied in future.
To see the effect of Blutal on the development of immunity, we made two different animal experiments by ref ering to Spivack et al. (1958) and Walker (1962) . These authors pointed out that immunization of guinea pigs with Fraction I sometimes brought about an immunounresponsiveness.
Therefore, we used, as immunogen, Fraction I in mice and live vaccine EV in guinea pigs. In the former case, Blutal suppressed the production of immunity; but, in the latter case, it exerted no effect on the development of protective immunity.
In these experiments with immunized mice, Blutal administration also seemed to have enhanced the virulence of the challenge strain of Yersinia pestis. If the Vol. 25 WAKE et al. virulent strain has a genetic potentiality to utilize tissue-bound iron , Blutal administration appears to have nothing to do with the virulence enhancement of the strain, unlike the case of EV.
In any case, from the data available , it is difficult to draw a conclusion.
